G. William Arends Professor of Obstetrics & Gynecology
Director, Center for Research on Women & Gender
Director, Center of Excellence in Women's Health
Bachelor of Arts in History, Northern Illinois University
MPA, School of Public, Administration and Policy, University of Arizona.
PhD, Department of Management and Policy, College of Business and Public Administration, University of Arizona
Stacie Geller, PhD is a health services researcher and epidemiologist with expertise in women's health issues, maternal mortality and morbidity, with a special emphasis on post-partum haemorrhage (PPH). She has a well-established national and international research career, having published over 75 peer-reviewed manuscripts, been awarded numerous research grants and conducted several NIH-funded clinical trials.
Dr. Geller’s work in maternal health focuses on factors associated with maternal mortality and morbidity. She was the Principal Investigator of a CDC/ASPH cooperative agreement "Investigation of factors associated with maternal mortality." She has developed an innovative model for early identification of high-risk pregnant women. Her international research in maternal mortality and morbidity began with a 5-year NICHD-funded randomized clinical trial comparing the use of oral misoprostol to placebo for the reduction postpartum haemorrhage in women delivering at home or in rudimentary health facilities in rural India. This has led to work with several other international agencies including the Gates and MacArthur Foundations, non-profit organizations and foreign governments to promote implementation of misoprostol into community based settings in the developing world.
Dr. Geller is currently conducting a study of two dosing strategies for the use of misoprostol in rural India. She recently completed a project to implement a continuum of care model to reduce PPH. In collaboration with the University of Otago and the New Zealand Ministry of Health, Dr. Geller has engaged in several initiatives to improve maternal health in Maori women.
Dr. Geller is the Principal Investigator of the National Institutes of Health-funded BIRCWH Program (Building Interdisciplinary Research Careers in Women’s Health), a K12 institutional career development grant for women’s health researchers, and has personally mentored many faculty members and fellows, particularly in the areas of research and career development.
Recent Publications & Presentations
KKominiarek MA, Scott S, Koch AR, Zeschke M, Cordova Y, Ravangard SF, Schy D and Geller SE. “Preventing maternal morbidity from obstetric haemorrhage: implications of a provider training initiative”. American Journal of Perinatology 2016;[Epub]
MacDonald EJ, Geller SE, and Lawton B. “Establishing a national severe maternal morbidity preventability review in New Zealand”. International Journal of Gynecology & Obstetrics 2016;[ePub]
Lawton B, Filoche S, Geller SE, Garrett S and Stanley J. “A retrospective cohort study of the association between midwifery experience and perinatal mortality”. International Journal of Gynecology & Obstetrics 2016;132(1):94-99.
Park J, Robinson N, Wessels U, Turner J, Geller S. “Progestin-based contraceptive on the same day as medical abortion”. International Journal of Gynecology & Obstetrics 2016; 133(2):217-20.
Wong CA, Scott S, Jones RL, Walzer J, Geller S. “The state of Illinois obstetric haemorrhage project: pre-project and post-training examination scores”. The Journal of Maternal-Fetal Neonatal Medicine 2016; 29(5):845-849.
Raghavan S, Geller S, Miller S, Goudar SS, Anger H, Yadavannavar MD, Dabash R, Bidri SR, Gudadinni MR, Udgiri R, Koch AR, Bellad MB, Winikoff B. “Misopristol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial”. British Journal of Obstetrics & Gynecology 2016;123(1):120-127.
MacDonald EJ, Lawton B, Geller SE. “Contraception post severe maternal morbidity: a retrospective audit”. Contraception 2015;92(4):308-312.
Lal AK, Geller S, Scott S, Hibbard JU. “Assessment of hospital readiness for obstetric haemorrhage”. Evidence Based Women’s Health Journal 2015;5(2):80-85.
Zimmermann K, Khare MM, Wright C, Hasler A, Kerch S, Moehring P, Geller SE. “Application of a gender-based approach to conducting a community health assessment for rural women in Southern Illinois”. Evaluation and Program Planning 2015;51:27-34.
Geller SE, Koch AR, Martin NJ, Rosenberg D, Bigger HR, for the Illinois Department of Public Health Maternal Mortality Review Committee Working Group. “Assessing preventability of maternal mortality in Illinois: 2002-2012”. American Journal of Obstetrics & Gynecology 2014; 211(6):698.e1-11.
Khare MM, Koch A, Zimmermann K, Moehring PA, Geller SE. “Heart Smart for Women: A community-based lifestyle change intervention to reduce cardiovascular risk in rural women”. Journal of Rural Health 2014;30(4):359-368.
Zimmermann K, Khare MM, Koch AR, Wright C, Geller S. “Training intervention study participants to disseminate health messages to the community: A new model for translation of clinical research to the community”. Clinical & Translational Science 2014;7(6):476-481.
Robinson N, Geller SE. “Recommendations for scale-up of community-based misoprostol distribution programs”. International Journal of Gynecology & Obstetrics 2014;125(3):285-288.
Lawton B, MacDonald EJ, Brown SA, Wilson L, Stanley J, Tait JD, Dinsdale RA, Coles CL, Geller SE. “Preventability of severe acute maternal morbidity”. American Journal of Obstetrics & Gynecology 2014;210(6):557.e1-6.
Fischer JH, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, Jeong H, Geller S, Deyo K, Fischer PA, Rodvold KA. “Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy”. Clinical Pharmacokinetics 2014;53(4):373-383.
Geller S, Carnahan L, Akosah E, Asare G, Agyemang R, Dickson R, Kapungu C, Owusu-Ansah, Robinson N, Mensah-Homiah J. “Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana”. British Journal of Obstetrics & Gynecology 2014;121(3):319-325.
Annual Meeting of the American Public Health Association, Chicago, November 2015.
Invited faculty, “Lessons learned from a community-based distribution of misoprostol to prevent postpartum haemorrhage in rural Ghana: recommendations for global maternal health policy and practice”.
Annual Meeting of the Centers for Disease Control/American Congress of Obstetricians and Gynecologists (CDC/ACOG) Maternal Safety/Maternal Mortality, San Francisco, CA. May 2015.
Invited faculty, “Maternal morbidity review”.
Healthy Texas Mothers & Babies Conference, Houston, TX, June 2015.
Invited faculty, “Maternal mortality review”
New Zealand Health Research Council. Program Grant to Reduce Maternal and Neonatal Morbidity. 2016-2020, Co-Principal Investigator.
New Zealand Health Research Council. Assessing Severe Morbidity in Infants of Mothers with Severe Acute Maternal Morbidity (SAMM). 2014-2017, Co-Principal Investigator.
Association of Maternal and Child Health Programs. Every Mother Initiative, 2014-2015, Co-Principal Investigator.
Illinois VENTURES. Testing of a prototype obstetrical medical device for auto transfusion in life threatening postpartum haemorrhage, 2014-2016, Co-Principal Investigator.
UIC Chancellor’s Discovery Fund for Multidisciplinary Pilot Research. Testing of a prototype obstetrical medical device for auto transfusion in life threatening postpartum haemorrhage, 2014-2016, Co-Principal Investigator.
New Zealand Health Research Council. Assessing Preventability of Severe and Near Miss Morbidity in New Zealand, 2013-2015, Co-Principal Investigator.
NIH/NICHD. Building Interdisciplinary Research Careers in Women’s Health (K12), 2012-2017, Principal Investigator.
New Zealand Health Research Council. Diabetes: Assessing the Impact on Maternal and Neonatal Health, 2012-2015, Principal Investigator.
Department of Health and Human Services/Office on Women’s Health. Coalition for Healthy
Communities – Phase II, 2011-2016, Principal Investigator.